Aprea Therapeutics Inc (NASDAQ: APRE) — Healthcare · Share Price, Chart & Market Data
About: Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.93 (+5.16%)
APREAprea Therapeutics Inc
Loading watchlist status…
Trade APRE now
Aprea Therapeutics Inc share price
APRE price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:04 am GMT+0
APRE price performance
2.491%
5D
36.149%
1M
9.015%
YTD
-46.863%
1Y
APRE price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:04 am GMT+0
APRE details
APRE Market Signals